subscribeSubscribe
price-trendAsk Us
Eagle to Present BYFAVO® (remimazolam) for Injection Abstract a

Eagle to Present BYFAVO® (remimazolam) for Injection Abstract a
GLOBENEWSWIRE
30 Aug 2023
Share Share
Eagle Pharmaceuticals Granted Unique J-Code for Byfavo®

Eagle Pharmaceuticals Granted Unique J-Code for Byfavo®
GLOBENEWSWIRE
01 May 2023
Share Share
Pain`s Byfavo (remimazolam) Approved In Europe

Pain`s Byfavo (remimazolam) Approved In Europe
EMA
16 Feb 2023
Share Share
Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural

Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural
GLOBENEWSWIRE
28 Jan 2021
Share Share
Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo NV

Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo NV
GLOBENEWLSWIRE
15 Jul 2020
Share Share
Cosmo Pharmaceuticals Announces US FDA Approval of BYFAVO™

Cosmo Pharmaceuticals Announces US FDA Approval of BYFAVO™
PRESS RELEASE
02 Jul 2020
Share Share
GHO Capital Acquires Ardena, a Leading CDMO

GHO Capital Acquires Ardena, a Leading CDMO
BUSINESS WIRE
09 Jan 2020
Share Share
Hana Pharm submits NDA for anesthetic agent

Hana Pharm submits NDA for anesthetic agent
BIOSPECTRUMASIA
31 Dec 2019
Share Share